It has been believed and thought ever since that aging is being caused by our own cell’s degeneration, and that nothing cannot prevent it or stop it. However, a new theory came out just recently stating that aging is just the continuous phase of growth, and a substance called rapamycin – if given in proper doses and schedules – could actually prevent sickness and diseases through the strengthening of the immune system and possibly prolong human life. Initially, this theory was ridiculed by scientists – but five years later, they realized how possible this theory could be executed in real life. The leading scientist and researcher for the anti-aging drug, Mikhail Blagosklonny, has been extending his effort and resources just to do extensive studies and researches about this particular field in medicine. He got his M.D. and PhD at the First Pavlov State Medical University of St. Petersburg, and right after graduation, he decided to work at the Roswell Park Cancer Institute as an oncology professor. Visit classroomvoices.org to read more about Mikhail.
Mikhail Blagosklonny formulated a hypothesis regarding rapamycin’s main role of target. He stated in this work that there could be possible signals in the aging process and the formulation of cancer, and how rapamycin is responsible for it. He proposed that the well-known cancer drug rapamycin can also be used to extend someone’s life by treating the aging process. A huge chunk of his time goes into the research of anti-aging drugs, and he is very passionate about it, working overtime just to get the results that he wanted. His research have also reached some of the major headlines in the United States lately, as Novartis, which is a major player in the pharmaceutical industry, have started creating a similar drug which aims to treat aging. It has the same component as the one Mikhail Blagosklonny is proposing, and they are doing it for the sake of human longevity. In the early days of his research, Mikhail Blagosklonny have found out how rapamycin can rejuvenate the body’s immune system, transforming an immunity that have been aging for a while to an immunity similar to that of an infant. In the span of the research, he also found out that rapamycin is safe and has no side effects. The potential with rapamycin is humongous, and its name is now echoing in the world of medicine. It was also given a title recently as the cornerstone of humanity’s quest to search for the fountain of youth.
Based on the research that were conducted inside the laboratory, it has been found out that rapamycin can stop the aging process with the help of its two centric models – MTOR and TOR. According to Mikhail Blagosklonny’s research, the TOR Centric Model can be divided into three sources, which are genetics, cellular senescence and diseases. In genetics, some findings have seen that a small number of genes possess the TOR Centric Model. For cellular senescence, it has been found out that deteriorating cells could revert back into fresh new cells with the help of rapamycin. Lastly, research shows that patients with Alzheimer’s disease, Parkinson’s disease, cancer and benign tumor have a good source of TOR Centric Model. For now, evidences are being gathered as to how these two centric models contribute to the possible ability of rapamycin to treat aging. The scientists and researchers have been working double time in order to introduce a prototype in the near future, so that one day, immortality would no longer a myth, but a reality – and we can thank people like Mikhail Blagosklonny for that. Read more on templeofthecave.com